A biotechnology company built on careful laboratory work

The name NovovitaBio joins "novo", new, with "vita", life. It describes what draws us to molecular biology: the way a few well-chosen experiments can turn a vague question about living systems into something you can actually measure.

NovovitaBio was founded in 2019 with a simple observation. Dependable molecular laboratory work is often out of easy reach for the people who need it: Master's students with a protocol that will not behave, researchers who need an assay checked before they commit to it, small teams without a fully equipped bench of their own. We set out to be the laboratory those people can turn to, and we have been building that way ever since.

Since that start we have grown into a provider of laboratory and research services built on molecular techniques, from RT-PCR and cell-based assays to protein purification and electrophoresis. Every project is treated as its own small story, with a question at the start and an interpreted result at the end.

We start with the question, not the technique. Before any sample is touched we want to know what you are trying to find out, what a useful answer would look like, and what could get in the way. Often that conversation changes the plan for the better.

Protocols are written before the work begins. Controls and replicates are part of the design rather than an afterthought, and observations are recorded as the work proceeds, so that any result can be traced back to how it was produced.

We would rather tell you that a method will not answer your question than run it anyway. When a result is uncertain, we say so and explain why. For us, a clear "not yet" is more useful than a confident answer that cannot be defended.

Our expertise is built at the bench. It centres on the everyday tools of molecular biology: preparing and handling nucleic acids, designing and running RT-PCR with the controls that make the data meaningful, culturing cells and measuring how they respond, purifying proteins, and separating and analysing both proteins and nucleic acids by electrophoresis.

Because these techniques are so often used together, we think in workflows rather than isolated methods. A good PCR result depends on the quality of the extraction that came before it; a clean purification depends on how the sample was prepared. Understanding those links is what lets us troubleshoot quickly when an experiment does something unexpected.

We also enjoy explaining the reasoning behind each step. Much of our work supports people who are still building their own laboratory skills, and we want them to finish a project understanding more than when they started.

Our main interest is molecular diagnostic research: how nucleic-acid detection assays are designed, what makes them reliable, and how their results should be read and reported. We are particularly interested in the unglamorous details that decide whether an assay can be trusted, such as control design, replicate strategy and the handling of ambiguous results.

Alongside that, we work on method development for cell-based assays and protein workflows, with an emphasis on reproducibility: protocols clear enough that another laboratory could follow them and reach the same place.

A third thread of our work is supporting research and project work carried out by students and early-career scientists. Helping someone design a cleaner experiment, or understand why one failed, is some of the most rewarding work we do.

For us, precision is a matter of habit rather than claim. Samples are handled and labelled consistently. Pre-amplification and post-amplification work are kept apart to limit contamination. Each run includes the controls needed to read it, and every step is documented well enough to be repeated.

We report results together with their limitations. A number without context is easy to misread, so we set out what was done, what the controls showed, and what the data can and cannot support.

If your project has regulatory, accreditation or quality-system requirements, please raise them when you first get in touch. We will tell you plainly whether and how we can meet them before any work begins.